CSIMarket Company Name, Ticker, Competitors, else..
 
Trxade Health Inc   (NASDAQ: MEDS)
Other Ticker:  
 
 
Price: $7.5900 $0.35 4.834%
Day's High: $7.7 Week Perf: 2.99 %
Day's Low: $ 7.06 30 Day Perf: -8 %
Volume (M): 19 52 Wk High: $ 23.77
Volume (M$): $ 143 52 Wk Avg: $2.39
Open: $7.25 52 Wk Low: $-30.09



 Market Capitalization (Millions $) 10
 Shares Outstanding (Millions) 1
 Employees -
 Revenues (TTM) (Millions $) -
 Net Income (TTM) (Millions $) 4
 Cash Flow (TTM) (Millions $) 2
 Capital Exp. (TTM) (Millions $) 0

Trxade Health Inc
Trxade Health Inc is a technology company that provides an online platform for pharmaceutical traders. They aim to connect independent pharmacies and healthcare professionals with suppliers and wholesalers, allowing them to purchase medicines at competitive prices. Their platform enables transparent and efficient transactions, eliminating middlemen and reducing costs for pharmacies. Trxade Health Inc also offers telemedicine services, allowing patients to consult with healthcare professionals remotely.


   Company Address: 6308 Benjamin Rd, Suite 708 Tampa 33634 FL
   Company Phone Number: 261-0281   Stock Exchange / Ticker: NASDAQ MEDS


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Stocks on the Move

s as it files its Q1 10-Q, which reveals positive net income following a strategic asset sale. This news showcases the companys ability to adapt and make smart business decisio...

Published Tue, Jul 23 2024 12:21 PM UTC

In recent trading sessions, the stock market has experienced notable shifts as several leading companies faced significant challenges. Salarius Pharmaceuticals witnessed a sharp decline in share value after receiving distressing news from the MD Anderson Cancer Center. Similarly, Selective Insurance Group reported disappointing quarterly results, causing a plummet in their s...
Trxade Health Inc

Trxade Health Inc. Takes the Lead with Stellar Performance Despite MEDS' Disappointing Results

Trxade Health Inc. (NASDAQ: MEDS) has showcased impressive financial performance in the first quarter of 2024, posting positive net income and signaling resilience in a challenging market environment. The company's earnings per share (EPS) stood at a substantial $16.77 per share, compared to a negative EPS of $-0.07 in the previous year, representing a significant turnaround.
What makes these results even more impressive is the fact that Trxade Health Inc. did not report any revenue for the quarter. Despite this, the company managed to achieve positive net income through an asset sale, highlighting its ability to adapt and find alternative sources of profitability.
Stocks on the Move

Trxade Health Inc. Reports Positive Net Income for Q1 2024 Amidst Challenging Market Conditions

Published Fri, Jun 28 2024 9:15 AM UTC

Trxade Health Inc. (NASDAQ: MEDS), a healthcare IT company that provides an integrated platform for pharmaceutical buyers and sellers, recently announced its financial results for the first quarter of 2024. Despite operating in a challenging market environment, the company reported positive net income, signaling potential resilience and adaptability. This article will analyz...
Trxade Health Inc

Trxade Health Inc Reports Significant Decline in Financial Performance during Recent Fiscal Period



Trxade Health Inc, a prominent player in the Pharmacy Services & Retail Drugstore industry, has recently reported a concerning decline in its financial performance. The most recent fiscal period has witnessed widening diminishing returns, increased net deficit, and considerable declines in revenue. These results are pivotal in understanding the current state of affairs and evaluating the company's future prospects. In this article, we will delve into Trxade Health Inc's financial results and provide a comprehensive analysis for investors and market participants.
The Financial Performance:
Trxade Health Inc's diminishing returns have drastically widened from $-0.06 per share a year ago to $-1.49 per share in the most recent fiscal period. This is undoubtedly a concerning trend, highlighting potential operational inefficiencies and financial challenges the company is facing. Additionally, the EPS improved to $-2.90 per share, showing some signs of recovery from the preceding quarter.
Trxade Health Inc

1. Trxade Health Inc: Revenue Plummets in Q2 of 2023, Sparking Concerns for Company's Future2. Breaking News: Trxade Health Inc Sees Significant Dip in Q2 2023 Revenue, Raises Alarm Bells

Trxade Health Inc, a healthcare services company that operates an online marketplace for pharmaceuticals, recently released its second-quarter 2023 financial report. Unfortunately, the report shows a weak business performance, resulting in a significant increase in losses compared to the same period last year.
One of the key metrics that highlights this decline is the net loss per share, which surged to $-2.90 from $-0.13. This indicates a substantial decrease in profitability for the company. Additionally, the revenue for the second quarter fell by 29.009% to $2.25 million, compared to $3.17 million in the previous year. This decline in revenue further emphasizes the challenges faced by Trxade Health Inc during this period.









Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com